期刊文献+

Cyanovirin-N蓝藻的筛选及其分子鉴定 被引量:1

Screening and Molecular Identification of Cyanobacteria Including Cyanovirin-N Gene,a HIV-inactivating Protein
下载PDF
导出
摘要 目的:从实验室培养的自生蓝藻中筛选出含有能编码抗病毒蛋白(cyanovirin-N,CV-N)基因的藻株并对其进行分子鉴定。方法:应用PCR技术和自行设计的特异性引物从80株蓝藻中筛选目标藻株,通过克隆、测序后,进行blast比对,经在线生物信息学软件预测该抗病毒蛋白CV-N的一级,二级,三级结构,并推测该基因序列编码的蛋白的抗病毒潜能。结果:筛选出藻株RZHA4,其所含的CV-N基因与已报道的CV-N基因有97%的相似性。结论:经16S rRNA-PCR和序列分析,该藻株与蓝藻Nostocaceae有99%的相似性,为一在实验室常规培养条件下生长良好的念珠藻(Nostoc),有可能成为新的CV-N生产藻株。 Objective:To screen a cyanobacterial isolate containing the gene encording Cyanovirin-N(CV-N) from free-living cyanobacterial strains cultured in the lab and to classify it molecularly.Method:Total 80 the algal strains/isolates were screened for CV-N gene using PCR with the primers designed specifically.The PCR product was cloned,sequenced,aligned through Blastn/Blastp and then predicted for the primary,secondary,and tertiary structural characteristics of the protein and potential functions of the putative Cyanovirin-N using the bioinformatic softwares on line.The target isolate was identified using 16S rRNA-PCR and sequence alignment.Result:A isolate RZHA4 carrying CV-N gene which had 97% similarity with the corresponding gene in GenBank.Conclusion:The RZHA4 was identified to belong to Nostocales due to 99% similarity on 16S rRNA sequence,being probably a new candidate for production of CV-N.Its potential function of antiviruses was speculated as well.
出处 《生物技术》 CAS CSCD 北大核心 2010年第6期54-57,共4页 Biotechnology
关键词 蓝藻 抗病毒蛋白-N 蛋白质结构 聚合酶链式反应 cyanobacteria cyanovirin-N protein structure PCR
  • 相关文献

参考文献20

  • 1Boyd MR,Gustafson KR,McMahon JB,et al.Discovery of cyanovirin-N,a novel human immunodeficiency virus-in-activating protein that binds viral surface envelope glycoprotein gp120:potential applications to microbicide development[J].Antimicrob Agents Chemother,1997,41(7):1521-1530.
  • 2Viviana Buffa,Daniel Stieh,Nahced Mamhood,et al.Shattock cyanovirin-N potently inhibits human immunodeficiency virus type Ⅰ infection in cellular and cervical explant models[J].Journal of General Virology,2009,90(1):234-243.
  • 3Tiwari V,Shukla SY,Shukla D.A sugar binding protein cyanovirin-N blocks herpes simplex virus type-1 entry and cell fusion[J].Antiviral Research,2009,84(1):67-75.
  • 4Barrientos LG,O Keefe BR,Bray M,et al.Cyanovirin-N binds to the viral surface glycoprotein,GP1,2 and inhibits infectivity of Ebola virus[J].Antiviral Research,2003,58(1):47-56.
  • 5Francois H,Czeslaw Wychowski,Ngoc Vu-Dac,et al.Cyanovirin-N inhibits hepatitis C vires entry by binding to envelope protein glycans[J].The Journal of Biological Chemistry,2006,281(35):25177-25183,.
  • 6Smee DF,Bailey KW,Wong MH,et al.Treatment of influenza A(H1N1)virus infections in mice and ferrets with cyanovirin-N[J].Antiviral Research,2008,80(3):266-271.
  • 7Koharudin LM,Viscomi AR,Jee JG,et al.The evolutianarily conserved family of cyanovirin-N homologs:structures and carbohydrate specificity[J].Structure,2008,16(4):570-584.
  • 8Matei E,Furey W,Gronenborn AM.Solution and crystal structures of a sugar binding site mutant of cyanevirin-N:No evidence of domain swapping[J].Structure,2008,16(8):1183-1194.
  • 9Buffa V,Stieh D,Mamhood N,et al.Cyanovirin-N potentlyy inhibits human immunodeficiency virus type 1 infection in cellular and cervical explant models[J].Journal of General Virology,2009 Jan,90(Pt 1):234-43.
  • 10齐小琼,高磊,苏应娟,王艇.CVNH结构域的进化分析和选择压力检测[J].遗传,2010,32(1):87-94. 被引量:3

二级参考文献62

  • 1李英辉,刘军,赵亚,薛采芳,丁劲,黄豫晓.HBV靶向核糖核酸酶基因的原核表达和纯化及多克隆抗体的制备[J].医学研究生学报,2005,18(4):295-297. 被引量:8
  • 2何小平,李兆申,屠振兴,高军,潘雪,龚燕芳,金晶.人canstatin基因原核载体构建及其重组蛋白的表达纯化[J].医学研究生学报,2005,18(11):981-985. 被引量:4
  • 3刘秀娜,潘自铁,王仙园,周娟,赵力军,胡川闽.人乳腺珠蛋白基因亚型的原核表达及纯化[J].医学研究生学报,2006,19(2):107-110. 被引量:2
  • 4刘玉生,李昌,金宁一,于芳,金洪涛.新型抗病毒蛋白CVN的构建及原核表达[J].免疫学杂志,2007,23(4):395-398. 被引量:3
  • 5Gustafson KR, Sowder RC 2nd, Henderson LE, Cardellina JH 2nd, McMahon JB, Rajamani U, Pannell LK, Boyd MR Isolation, primary sequence determination, and disulfide bond structure of cyanovirin-N, an anti-HIV (human immunodeficiency virus) protein from the cyanobacterium Nostoc ellipsosporum. Biochem Biophys Res Commun, 1997, 238(1): 223-228.
  • 6Barrientos LG, O'Keefe BR, Bray M, Sanchez A, Gronenborn AM, Boyd MR. Cyanovirin-N binds to the viral surface glycoprotein, GP1, 2 and inhibits infectivity of Ebola virus. Antivir Res, 2003, 58(1): 47-56.
  • 7Boyd MR, Gustafson KR, McMahon JB, Shoemaker RH, O'Keefe BR, Mori T, Gulakowski RJ, Wu L, Rivera MI, Laurencot CM, Currens M J, Cardellina JH 2nd, Buckheit RW Jr, Nara PL, Pannell LK, Sowder RC 2nd, Henderson LE. Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development. Antirnicrob Agents Chemother, 1997, 41(7): 1521-1530.
  • 8Bewley CA, Gustafson KR, Boyd MR, Covell DG, Bax A, Clore GM, Gronenborn AM. Solution structure of cyano- virin-N, a potent HIV-inactivating protein. Nat Struct Biol, 1998, 5(7): 571-578.
  • 9Bolmstedt AJ, O'Keefe BR, Shenoy SR, McMahon JB, Boyd MR. Cyanovirin-N defines a new class of antiviral agent targeting N-linked, high-mannose glycans in an oligosaccharide-specific manner. Mol Pharmacol, 2001, 59(5): 949-954.
  • 10O'Keefe BR, Smee DF, Turpin JA, Saucedo CJ, Gustafson KR, Mori T, Blakeslee D, Buckheit R, Boyd MR. Potent anti-influenza activity of cyanovirin-N and interactions with viral hemagglutinin. Antimicrob Agents Chemother, 2003, 47(8): 2518-2525.

共引文献13

同被引文献17

  • 1Boyd M R. Discovery of cyanovirin-N, a novel human im- munodeficiency virus-inactivating protein that binds viral surface envelope glyeoprotein gpl20: potential applications to microbieide development [J] . Antimierobial Agents and Chemotherapy, 1997, 41 (7) : 1 521-1 530.
  • 2Matei E. Solution and crystal structures of a sugar binding site mutant of eyanovirin-N: No evidence of domain swap- ping [J] . Structure, 2008, 16 (8) : 1 183-1 194.
  • 3Botos I. Cyanovirin-N: a sugar-binding antiviral protein with a new twist [J] . Cellular and Molecular Life Sciences, 2003, 60 (5): 277-287.
  • 4O'Keefe B R. Potent anti-influenza activity of cyanovirin-N and interactions with viral hemagglutinin [J] . Antimicrobial Agents and Chemotherapy, 2003, 47 (8) : 2 518-2 525.
  • 5Colleluori D M. Expression, purification, and characteriza- tion of recombinant cyanovirin-N for vaginal anti-HIV mi- crobicide development [J] . Protein Expression and Purifi- cation. 2005. 39 (2): 229-236.
  • 6Giomarelli B. The microbicide cyanovirin-N expressed on the surface of commensal bacterium Streptococcus gordonii captures HIV-1 [J] . AIDS, 2002, 16 (10) : 1 351-1 356.
  • 7Xu Q. Vaginal Lactobacilli for mueosal delivery of the anti- HIV microbicide, Cyanovirin-N (CV-N)[J]. Retrovirol- ogy, 2005, 2 (12): 87.
  • 8Lagenaur L A. Development of vaginal Lactobacilli for mu- cosal delivery of a topical mierobicide, Cyanovirin-N(CV-N) [J]. Retrovirology, 2005, 2 (12): 93.
  • 9Pusch O. Bioengineering lactic acid bacteria to secrete the HIV-I virueide eyanovirin [J] . Journal of Acquired Im- mune Deficiency Syndromes, 2005, 40 (5): 512-520.
  • 10Sexton A. Transgenic plant production of Cyanovirin-N, an HIV microbicide [ J] . The FASEB Journal, 2006, 20 (2) : 356-358.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部